Literature DB >> 2297206

The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.

G H Guyatt1, J L Keller, R Jaeschke, D Rosenbloom, J D Adachi, M T Newhouse.   

Abstract

OBJECTIVE: To review the feasibility and effectiveness of n-of-1 randomized controlled trials (n-of-1 trials) in clinical practice.
DESIGN: Individual trials were double-blind, randomized, multiple crossover trials. The impact of n-of-1 trials was determined by eliciting physicians' plans of management and confidence in those plans before and after each trial.
SETTING: Referral service doing n-of-1 trials at the requests of community and academic physicians. OBJECT of ANALYSIS: All trials were planned, started, and completed by the n-of-1 service. MEASURES OF OUTCOME: The proportion of planned n-of-1 trials that were completed and the proportion that provided a definite clinical or statistical answer. A definite clinical answer was achieved if an n-of-1 trial resulted in a high level of physician's confidence in the management plan. Specific criteria were developed for classifying an n-of-1 trial as providing a definite statistical answer. MAIN
RESULTS: Seventy-three n-of-1 trials were planned in various clinical situations. Of 70 n-of-1 trials begun, 57 were completed. The reasons for not completing n-of-1 trials were patients' or physicians' noncompliance or patients' concurrent illness. Of 57 n-of-1 trials completed, 50 provided a definite clinical or statistical answer. In 15 trials (39% of trials in which appropriate data were available), the results prompted physicians to change their "prior to the trial" plan of management (in 11 trials, the physicians stopped the drug therapy that they had planned to continue indefinitely).
CONCLUSION: We interpret the results as supporting the feasibility and usefulness of n-of-1 trials in clinical practice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297206     DOI: 10.7326/0003-4819-112-4-293

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  87 in total

Review 1.  To whom do the research findings apply?

Authors:  Curt D Furberg
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

2.  Looking at effectiveness: ideas from the couch.

Authors:  J Firth-Cozens
Journal:  Qual Health Care       Date:  1996-03

3.  Use of double-blind placebo-controlled N-of-1 trials among stimulant-treated youths in The Netherlands: a descriptive study.

Authors:  Adrianne Faber; Ron J Keizer; Paul B van den Berg; Lolkje T W de Jong-van den Berg; Hilde Tobi
Journal:  Eur J Clin Pharmacol       Date:  2006-11-18       Impact factor: 2.953

Review 4.  Monitoring in chronic disease: a rational approach.

Authors:  Paul Glasziou; Les Irwig; David Mant
Journal:  BMJ       Date:  2005-03-19

5.  The challenges of evidence-based medicine: a philosophical perspective.

Authors:  Abhaya V Kulkarni
Journal:  Med Health Care Philos       Date:  2005

6.  N-of-1 trials: an opportunity to tailor treatment in individual patients.

Authors:  Vishnu Madhok; Tom Fahey
Journal:  Br J Gen Pract       Date:  2005-03       Impact factor: 5.386

Review 7.  Use of the single subject design for practice based primary care research.

Authors:  J E Janosky
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

8.  N-of-1 Randomized Trials of Ultra-Micronized Palmitoylethanolamide in Older Patients with Chronic Pain.

Authors:  Federico Germini; Anna Coerezza; Luca Andreinetti; Alessandro Nobili; Paolo Dionigi Rossi; Daniela Mari; Gordon Guyatt; Maura Marcucci
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

9.  Treatment of chronic depression with sulpiride: evidence of efficacy in placebo-controlled single case studies.

Authors:  W Maier; O Benkert
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

Review 10.  Reversing stroke in the 2010s: lessons from Desmoteplase In Acute ischemic Stroke-2 (DIAS-2).

Authors:  David S Liebeskind
Journal:  Stroke       Date:  2009-07-16       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.